Guidance in topic selection
Showing 1 to 2 of 2
Title | Technology type | Decision | Decision date |
---|---|---|---|
Budesonide–glycopyrronium–formoterol fumarate for treating severe asthma in people 12 years and over TS ID 12018 | Medicine | Not selected | |
Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TSID10085] | Medicine | Not selected |